Cargando…

Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin

Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price le...

Descripción completa

Detalles Bibliográficos
Autor principal: Kreling, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1989
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192959/
https://www.ncbi.nlm.nih.gov/pubmed/10313098
_version_ 1782338879329665024
author Kreling, David H.
author_facet Kreling, David H.
author_sort Kreling, David H.
collection PubMed
description Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price less 10.5 percent for other products or wholesaler cost plus 5.01 percent for all products. The resulting overall average ingredient cost reimbursement reductions were 6.64 percent ($0.56 per prescription) and 6.94 percent ($0.59 per prescription) for the two methods, respectively. The results should be viewed from the perspective of both program savings and reduced pharmacists' revenues.
format Online
Article
Text
id pubmed-4192959
institution National Center for Biotechnology Information
language English
publishDate 1989
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41929592014-11-04 Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin Kreling, David H. Health Care Financ Rev Research Article Potential impacts from two methods of changing prescription drug ingredient reimbursement in the Wisconsin Medicaid program were estimated. Current reimbursement amounts were compared with those resulting from either direct prices for eight manufacturers' products and average wholesale price less 10.5 percent for other products or wholesaler cost plus 5.01 percent for all products. The resulting overall average ingredient cost reimbursement reductions were 6.64 percent ($0.56 per prescription) and 6.94 percent ($0.59 per prescription) for the two methods, respectively. The results should be viewed from the perspective of both program savings and reduced pharmacists' revenues. CENTERS for MEDICARE & MEDICAID SERVICES 1989 /pmc/articles/PMC4192959/ /pubmed/10313098 Text en
spellingShingle Research Article
Kreling, David H.
Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title_full Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title_fullStr Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title_full_unstemmed Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title_short Assessing potential prescription reimbursement changes: Estimated acquisition costs in Wisconsin
title_sort assessing potential prescription reimbursement changes: estimated acquisition costs in wisconsin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192959/
https://www.ncbi.nlm.nih.gov/pubmed/10313098
work_keys_str_mv AT krelingdavidh assessingpotentialprescriptionreimbursementchangesestimatedacquisitioncostsinwisconsin